Author

J.-X. Li

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Organism:Arabidopsis· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

B. Zheng· 1 shared B.-L. Zhu· 1 shared C. Dufour· 1 shared C.-F. Qin· 1 shared F.-C. Zhu· 1 shared G. Chen· 1 shared H.-C. Chen· 1 shared H.-X. Pan· 1 shared

Activity by Year

2017-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Zheng

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Wounding perception by jasmonate-mediated JAZ condensation in plants

Z.-W. Yan, J. Liu, H.-C. Chen, M.-Y. Wang, W.-J. Cai, J.-X. Li, J.-W. Wang, Y.-B. Mao

This study reveals that JAZ1 undergoes phase separation in response to wounding, facilitating rapid jasmonate signaling by reducing its interaction with MYC2 and recruiting COI1 for degradation.

bioRxiv · Mar 28, 2024 · PreprintPlant Biology

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2

L. Zhang, L. Cao, X. Gao, B. Zheng, Y. Deng, J.-X. Li, R. Feng, Q. Bian, X.-L. Guo, N. Wang, H.-Y. Qiu, L. Wang, Z. Cui, Q. Ye, G. Chen, , F.-C. Zhu

A cocktail of neutralizing antibodies targeting SARS-CoV-2 spike protein's NTD and RBD, when used as immunogens in rabbits, elicited strong protective immune responses.

bioRxiv · Sep 23, 2020Microbiology

Gene knockout shows that PML (TRIM19) does not restrict the early stages of HIV-1 infection in human cell lines

N. Masroori, P. Cherry, N. Merindol, J.-x. Li, C. Dufour, L. Poulain, M. B. Plourde, L. Berthoux

This paper uses CRISPR-Cas9 to knockout PML in human cell lines and shows it does not restrict early HIV-1 infection or IFN-I-mediated inhibition.

bioRxiv · May 21, 2017Immunology